Home
Scholarly Works
Efficacy And Safety Of A Cxcr2 Antagonist,...
Conference

Efficacy And Safety Of A Cxcr2 Antagonist, Azd5069, In Severe, Uncontrolled Persistent Asthma

Authors

O'Byrne PM; Metev H; Puu M; Richter K; Keen C

Volume

191

Publisher

AMER THORACIC SOC

Publication Date

January 1, 2015

Name of conference

International Conference of the American-Thoracic-Society (ATS)

Conference place

Denver, CO

Conference start date

May 15, 2015

Conference end date

May 20, 2015

Conference proceedings

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

ISSN

1073-449X

Contact the Experts team